Dexamethasone antagonizes IL-4 and IL-10-induced release of IL-1RA by monocytes but augments IL-4-, IL-10-, and TGF-β-induced suppression of TNF- α release

Journal of Interferon and Cytokine Research

Volumn 16, Issue 7, 1996, Pages 511-517

  Joyce, David A ^a   Steer, James H ^a   Kloda, Anna ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DEXAMETHASONE; GLUCOCORTICOID; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MONOKINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; BLOOD CULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL;

EID: 0029816982     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1996.16.511     Document Type: Article

References (45)

1. AREND, W.P., and DAYER, J.-M. (1995). Inhibition of the production and effects of interleukin-1 and tumor necrosis factor-α in rheumatoid arthritis. Arthritis Rheum. 38, 151-160.
2. FELDMANN, M., BRENNAN, F.M., ELLIOTT, M., KATSIKIS, P., and MAINI, R.N. (1994). TNF-α as a therapeutic target in rheumatoid arthritis. Circ. Shock 43, 179-184.
3. STRIETER, R.M., KUNKEL, S.L., and BONE, R.C. (1993). Role of tumor necrosis factor-α in disease states and inflammation. Crit. Care Med. 21, S447-463.
4. DINARELLO, C.A., and WOLFF, S.M. (1993). The role of interleukin-1 in disease. N. Engl. J. Med. 328, 106-113.
5. BOUMPAS, D.T., CHROUSOS, G.P., WILDER, R.L., CUPPS, T.R., and BALOW, J.E. (1993). Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann. Int. Med. 119, 1198-1208.
6. AMANO, Y., LEE, S.W., and ALLISON, A.C. (1993). Inhibition by glucocorticoids of the formation of interleukin-1α, interleukin-1β, and interleukin-6: mediation by decreased mRNA stability. Mol. Pharmacol. 43, 176-182.
7. STANDIFORD, T.J., KUNKEL, S.L., ROLFE, M.W., EVANOFF, H.L., ALLEN, R.M., and STRIETER, R.M. (1992). Regulation of human alveolar macrophage- and blood monocyte-derived interleukin-8 by prostaglandin E2 and dexamethasone. Am. J. Respir. Cell Mol. Biol. 6, 75-81.
8. HART, P.H., WHITTY, G.A., BURGESS, D.R., CROATTO, M., and HAMILTON, J.A. (1990). Augmentation of glucocorticoid action on human monocytes by interleukin-4. Lymphokine Res. 9, 147-153.
9. AREND, W.P., WEGUS, H.G., THOMPSON, R.C., and EISENBERG, S.P. (1990). Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. J. Clin. Invest. 85, 1694-1697.
10. JOYCE, D.A., and STEER, J.H. (1995). Tumor necrosis factor-α and interleukin-1α stimulate late shedding of p75 TNF receptors but not p55 TNF receptors from human monocytes. J. Interferon Cytokine Res. 15, 947-954.
11. DE WAAL MALEFYT R., ABRAMS, J., BENNETT, B., FIGDOR, C.G., and DE VRIES, J.E. (1991). Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174, 1209-1220.
12. 2. Proc. Natl. Acad. Sci. USA 86, 3803-3807.
13. BOGDAN, C., and NATHAN, C. (1993). Modulation of macrophage function by transforming growth factor-β, interleukin-4, and interleukin-10. Ann. NY Acad. Sci. 685, 713-739.
14. KATSIKIS, P., CHU, C., BRENNAN, F.M., MAINI, R.N., and FELDMANN, M. (1994). Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J. Exp. Med. 179, 1517-1527.
15. GERARD, C., BRUYNS, C., MARCHANT, A., ABRAMOWICZ, D., VANDENABEELE, P., DELVAUX, A., FIERS, W., GOLDMAN, M., and VELU, T. (1993). Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177, 547-550.
16. MOSMANN, T.R. (1994). Properties and functions of interleukin-10. Adv. Immunol. 56, 1-26.
17. PAUL, W.E. (1991). Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 77, 1859-1870.
18. BERGER, A.E., CARTER, D.B. HANKEY, S.O., and McEWAN, R.N. (1993). Cytokine regulation of the interleukin-1 receptor antagonist protein in U937 cells. Eur. J. Immunol. 23, 39-45.
19. CHOMARAT, P., VANNIER, E., DECHANET, J., RISSOAN, M.C., BANCHEREAU, J., DINARELLO, C.A., and MIOSSEC, P. (1995). Balance of IL-1 receptor antagonist/IL-1β in rheumatoid synovium and its regulation by IL-4 and IL-10. J. Immunol. 154, 1432-1439.
20. JOYCE, D.A., GIBBONS, D.P., GREEN, P., STEER, J.H., FELDMANN, M., and BRENNAN, F.M. (1994). Two inhibitors of pro-inflammatory cytokine release, IL-10 and IL-4, have contrasting effects on the release of soluble p75 TNF receptor by cultured human monocytes. Eur. J. Immunol. 24, 2699-2705.
21. JOYCE, D.A., STEER, J.H., BEILHARZ, M., and STRANGER, R. (1995). A system for assessment of monokine gene expression using human whole blood. Genet. Anal. Biomol. Eng. 12, 39-43.
22. PHILLIPS, W.G., FELDMANN, M., BREATHNACH, S.M., and BRENNAN, F.M. (1995). Modulation of the IL-1 cytokine network in keratinocytes by intracellular IL-1α and IL-1 receptor antagonist. Clin. Exp. Immunol. 101, 177-182.
23. ORINO, E., SONE, S., NII, A., and OGURA, T. (1992). IL-4 upregulates IL-1 receptor antagonist gene expression and its production in human blood monocytes. J. Immunol. 149, 925-931.
24. CASSATELLA, M.A., MEDA, L., GASPERINI, S., CALZETTI, P., and BONORA, S. (1994). Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J. Exp. Med. 179, 1695-1699.
25. BOGDAN, C., PAIK, J., VODOVOTZ, Y., and NATHAN, C. (1992). Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J. Biol. Chem. 267, 23301-23308.
26. TURNER, M., CHANTRY, D., KATSIKIS, P., BERGER, A., BRENNAN, F.M., and FELDMANN, M. (1991). Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-β. Eur. J. Immunol. 21, 1635-1639.
27. WAHL, S.M., COSTA, G.L., CORCORAN, M., WAHL, L.M., and BERGER, A.E. (1993). Transforming growth factor-β mediates IL-1-dependent induction of IL-1 receptor antagonist. J. Immunol. 150, 3553-3560.
28. TURNER, M., CHANTRY, D., and FELDMANN, M. (1990). Transforming growth factor β induces the production of interleukin 6 by human peripheral blood mononuclear cells. Cytokine 2, 211-216.
29. TAIPALE, J., MATIKAINEN, S., HURME, M., and KESKI-OJA, J. (1994). Induction of transforming growth factor β1 and its receptor expression during myeloid leukemia cell differentiation. Cell Growth Differ. 5, 1309-1319.
30. FALCONE, D.J., McCAFFREY, T.A., MATHEW, J., McADAM, K., and BORTH, W. (1995). THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-β1 via increased expression of urokinase and the urokinase receptor. J. Cell. Physiol. 164, 334-343.
31. WANG, P., WU, P., SIEGEL, M.I., EGAN, R.W., and BILLAH, M.M. (1995). Interleukin (IL)-10 inhibits nuclear factor kappaB (NFkappaB) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J. Biol. Chem. 270, 9558-9563.
32. WANG, P., WU, P., SIEGEL, M.I., EGAN, R.W., and BILLAH, M.M. (1994). IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J. Immunol. 153, 811-817.
33. MOREIRA, A.L., SAMPAIO, E.P., ZMUIDZINAS, A., FRINDT, P., SMITH, K.A., and KAPLAN, G. (1993). Thalidomide exerts its inhibitory action on tumor necrosis factor-α by enhancing mRNA degradation. J. Exp. Med. 177, 1675-1680.
34. TRAN-THI, T.A., DECKER, K., and BAEUERLE, P.A. (1995). Differential activation of transcription factors NF-kappa B and AP-1 in rat liver macrophages. Hepatology 22, 613-619.
35. NEWELL, C.L., DEISSEROTH, A.B., and LOPEZ-BERESTEIN, G. (1994). Interaction of nuclear proteins with an AP-1/CRE-like promoter sequence in the human TNF-α gene. J. Leukocyte Biol. 56, 27-35.
36. SCHEINMAN, R.I., GUALBERTO, A., JEWELL, C.M., CIDLOWSKI, J.A., and BALDWIN A.S., Jr. (1995). Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol. Cell. Biol. 15, 943-953.
37. SCHEINMAN, R.I., COGSWELL, P.C., LOFQUIST, A.K., and BALDWIN, A.S. (1995). Role of transcriptional activation of I-kappaBα in mediation of immunosuppression by glucocorticoids. Science 270, 283-286.
38. AUPHAN, N., DiDONATO, J.A., ROSETTE, C., HELMBERG, A., and KARIN, M. (1995). Immunosuppression by glucocorticoids: inhibition of NF-kappaB activity through induction of I-kappaB synthesis. Science 270, 286-290.
39. JENKINS, J.K., MALYAK, M., and AREND, W.P. (1994). The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1β production in human monocytes and neutrophils. Lymphokine Cytokine Res. 13, 47-54.
40. ARZT, E., SAUER, J., POLLMACHER, T., LABEUR, M., HOLSBOER, F., REUL, J.M., and STALLA, G.K. (1994). Glucocorticoids suppress interleukin-1 receptor antagonist synthesis following induction by endotoxin. Endocrinology 134, 672-677.
41. ALLEN, J.B., WONG, H.L., COSTA, G.L., BIENKOWSKI, M.J., and WAHL, S.M. (1993). Suppression of monocyte function and differential regulation of IL-1 and IL-1RA by IL-4 contribute to resolution of experimental arthritis. J. Immunol. 151, 4344-4351.
42. CHERNOFF, A.E., GRANOWITZ, E.V. SHAPIRO, L., VANNIER, E., LONNEMANN, G., ANGEL, J.B., KENNEDY, J.S., RABSON, A.R., WOLFF, S.M., and DINARELLO, C.A. (1995). A randomized, controlled trial of IL-10 in humans: inhibition of inflammatory cytokine production and immune responses. J. Immunol. 154, 5492-5499.
43. ATKINS, M.B., VACHINO, G., TILG, H.J., KARP, D.D., ROBERT, N.J., KAPPLER, K., and MIER, J.W. (1992). Phase I evaluation of thrice-daily intravenous bolus interleukin-4 in patients with refractory malignancy. J. Clin. Oncol. 10, 1802-1809.
44. POWRIE, F., MENON, S., and COFFMAN, R.L. (1993). Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur. J. Immunol. 23, 3043-3049.
45. ROUX-LOMBARD, P., MODOUX, C., and DAYER, J.-M. (1989). Production of interleukin-1 (IL-1) and a specific IL-1 inhibitor during monocyte-macrophage differentiation: influence of GM-CSF. Cytokine 1, 45-51.